However, according to the provisional data catalogued in the cBioPortal platform for cancer genomics [33], HSD11B1 amplification might occur in varying but significant proportions of common cancers, such as prostate (13.6–26.2%), breast (9.5–17.6%), and renal cell (9.1%) carcinomas. This evidence concerns the gene HSD11B1 and cancer.